What does negative hepatitis B antibody mean?
Sep 13, 2022
Source: Cainiu Health
Dr. Jin Zhongkui
Introduction
If the hepatitis B antibody is negative—specifically the second item in the hepatitis B five-panel test, the hepatitis B surface antibody—a negative result indicates the absence of protective antibodies. This means that upon exposure to the hepatitis B virus, infection can easily occur, especially in preschool-aged children. Without existing antibodies, it takes time for the body to develop them after vaccination. For adults, however, even without detectable antibodies, the risk of infection remains very low.
Hepatitis B is a condition that most people are familiar with in daily life, and many even understand how it develops. But what does it mean when the hepatitis B antibody test result is negative?
What Does a Negative Hepatitis B Antibody Test Mean?
A negative hepatitis B antibody refers to the second item in the hepatitis B five-panel test—the hepatitis B surface antibody (HBsAb). A negative result indicates the absence of protective antibodies. If exposed to the hepatitis B virus, individuals without antibodies are at high risk of infection, especially preschool-aged children. Without existing immunity, it takes time for the body to produce antibodies after vaccination. In adults, however, the risk of infection remains low even without detectable antibodies.
Hepatitis B antibody testing is one component of the standard screening panel. The first item typically tested is the hepatitis B surface antibody. A negative result means the individual lacks immunity against hepatitis B, thus facing relatively higher risk and susceptibility to hepatitis B virus infection. However, in cases where adults are exposed to the virus, hepatitis B immunoglobulin (HBIG) can be administered as emergency prophylaxis, effectively protecting exposed individuals from infection. This preventive measure can help shield exposed individuals from contracting hepatitis B virus.
If liver function tests reveal elevated transaminase or bilirubin levels, this may indicate an active hepatitis flare, which requires antiviral treatment. First-line antiviral medications such as entecavir and tenofovir can effectively suppress hepatitis B virus replication, slow the progression of liver fibrosis and cirrhosis, and reduce the risk of developing liver cancer. We hope this information has been helpful. Wishing you good health and a happy life!
